The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025.
SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance – Biotech Investments
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Development of Sales/Annual Results SCHOTT Pharma delivers right after IPO with strong profitable growth for